Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825627 | Clinical Therapeutics | 2013 | 11 Pages |
Abstract
These findings suggest that the test formulation of lamivudine 100 mg meets the FDA regulatory standards for bioequivalence with the reference formulation. Both formulations were well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Xiaojiao MD, Bin PhD, Yanfu BD, Haiyan MD, Hong MD, Hong PhD, Qi BD, Yanhua PhD,